Safe : Minimal side effects and approved for long-term use
Why a lean, healthy 34-year-old doctor takes low-dose tirzepatide Dr
Patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, uncontrolled diabetes, or severe renal impairment should not use GLP-1 medications
Symptoms of pain (or tenderness to touch), bleeding and itching should be elicited if not volunteered, as they suggest a growing, invasive or irritated lesion
Each of these medications changes how your hunger hormones behave, so when you discontinue treatment, those hormones gradually return to their baseline
Clin Pharmacokinet 60:13351348 Petri KCC, Ingwersen SH, Flint A, Zacho J, Overgaard RV (2018) Exposure-response analysis for evaluation of semaglutide dose levels in type 2 diabetes